Evidence map›Paper›PMID 41125244›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes.

Jonas Brügger, Corinne Isenegger, Fabian Jordan, Behnam Subin, Reto Stump, Sven Knecht, David Spreen, Nicolas Schaerli, Philipp Krisai, Beat Schaer and 4 more

Abstract readComparative Study
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Guideline
  2. Article
  3. Article
  4. Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jonas BrüggerDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0009-0003-6123-8362
Corinne IseneggerDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0009-0001-9623-3997
Fabian JordanDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0009-0004-4831-7274
Behnam SubinDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0002-4997-9841
Reto StumpDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0001-5856-9177
Sven KnechtDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0001-7122-021X
David SpreenDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0009-0002-0356-2394
Nicolas SchaerliDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0002-6499-5866
Philipp KrisaiDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0002-4367-2363
Beat SchaerDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0003-1768-1968
Felix MahfoudDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0002-4425-549X
Christian SticherlingDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0001-8428-7050
Michael KühneDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0002-2937-3711
Patrick BadertscherDepartment of Cardiology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland.ORCID 0000-0001-9751-0557

Funding

Swiss Heart FoundationUniversity of Basel
6 · The paper itself

Abstract

aimsPulsed-field ablation (PFA) is a non-thermal energy source for pulmonary vein isolation (PVI), offering advantages in safety and procedural efficiency. However, data comparing anterior mitral isthmus line (MIL) ablation using PFA vs. conventional radiofrequency ablation (RFA) are scarce. This study aimed to compare procedural characteristics, safety, and arrhythmia recurrence following PVI with additional anterior MIL ablation using PFA vs. RFA. METHODS AND

resultsIn this prospective, single-centre analysis from the SWISS-AF-PVI registry, 129 patients (median age 70 years, 40% female) undergoing PVI with anterior MIL ablation were included. Patients received either PFA with a pentaspline catheter (n = 61) or RFA using a 3.5 mm irrigated tip catheter (n = 68). Procedural parameters, complications, and arrhythmia recurrence were assessed over a median follow-up of 327 days. PFA significantly reduced total procedure time (71 vs. 108 min, P < 0.001), LA dwell time (53 vs. 80 min, P < 0.001), and ablation time (27 vs. 50 min, P < 0.001) compared to RFA. MIL ablation with PFA required fewer applications (14; 35 s vs. 473 s RFA, P < 0.001). Arrhythmia-free survival was similar between groups (PFA 48.8% vs. RFA 61.8%, P = 0.34). Among 34 patients undergoing redo procedures, incomplete MIL was found in 53%, with no significant difference between groups. Three major complications occurred.

conclusionAnterior MIL ablation using PFA is feasible, safe, and more time-efficient than RFA, with comparable mid-term arrhythmia outcomes. However, high rates of MIL reconnection and arrhythmia recurrence highlights the need to improve lesion durability.

Indexed as

Atrial FibrillationCardiac CathetersCatheter AblationMitral ValvePulmonary VeinsAction PotentialsAgedEquipment DesignFemaleHumansMaleMiddle AgedOperative TimeProspective StudiesRecurrenceRegistriesAnterior lineAtrial fibrillationMitral isthmus linePulmonary vein isolationPulsed-field ablationRadiofrequency ablation

Identifiers

PMID41125244
PMCPMC12585187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.